XTL-Pseudomonas-MAb (XTL Biopharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameXTL-Pseudomonas-MAb (XTL Biopharmaceuticals)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPseudomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXtl Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXtl Biopharmaceuticals
Active IndicationsN/A
Inactive IndicationsPseudomonas Infections

Other Information

ATC CodeN/A
Related LinksN/A